NCT03975790 Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTX Status COMPLETED Phase N/A
NCT03974776 Singe Dose Study of PF- 06946860 in Healthy Adult Japanese Participants Status COMPLETED Phase PHASE1
NCT03974217 Talazoparib for Cohesin-Mutated AML and MDS With Excess Blasts Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03973918 Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG Status TERMINATED Phase PHASE2
NCT03971409 Avelumab With Binimetinib, Sacituzumab Govitecan, or Liposomal Doxorubicin in Treating Stage IV or Unresectable, Recurrent Triple Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03970733 Alternative Schedule Study For VLA15, a Vaccine Candidate Against Lyme Borreliosis Status COMPLETED Phase PHASE2
NCT03969719 A Double-blind Study to Assess 2 Doses of an Investigational Product for 16 Weeks in Participants With Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus Status COMPLETED Phase PHASE2
NCT03969121 Neoadjuvant Hormonal Therapy Plus Palbociclib in Operable, Hormone Sensitive and HER2-Negative Primary Breast Cancer Status COMPLETED Phase PHASE3
NCT03964649 Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics Status COMPLETED Phase N/A
NCT03964532 TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03963401 A Study to Evaluate the Efficacy and Safety of PF-06700841 in Subjects With Active Psoriatic Arthritis Status COMPLETED Phase PHASE2
NCT03962465 Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Patients With Relapsed/Refractory B-cell ALL Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03961997 Effect of Multiple Doses of Modafinil on the Pharmacokinetics of Single Dose Lorlatinib in Healthy Participants Status COMPLETED Phase PHASE1
NCT03954158 Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis Status COMPLETED Phase PHASE2
NCT03950232 An Extension Study for Treatment of Moderately to Severely Active Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT03943615 Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options Status NO_LONGER_AVAILABLE Phase N/A
NCT03938792 Study of the Efficacy and Safety PF-06741086 in Adult and Teenage Participants With Severe Hemophilia A or Moderately Severe to Severe Hemophilia B Status COMPLETED Phase PHASE3